ClinicalTrials.gov
ClinicalTrials.gov Menu

HER-2 Pulsed DC Vaccine to Prevent Recurrence of Invasive Breast Cancer (Adjuvant)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02063724
Recruitment Status : Active, not recruiting
First Posted : February 14, 2014
Last Update Posted : December 15, 2017
Sponsor:
Collaborator:
Abramson Cancer Center of the University of Pennsylvania
Information provided by (Responsible Party):
H. Lee Moffitt Cancer Center and Research Institute

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Active, not recruiting
  Estimated Primary Completion Date : December 2018
  Estimated Study Completion Date : December 2019
Publications: